VNDA: שולי רווח תפעולי vandapharma.com

The assessment of Vanda Pharmaceuticals (VNDA) operating profitability demonstrates the market's reaction to the business's resilience against macro shocks due to the critical nature of psychiatric medications. Stable production of sleep aids relies on a strong patent portfolio, although FDA oversight and litigation weaken defenses against generics. The current level of -77.60 captures fresh values for the company's core operating profitability.
Vanda Pharmaceuticals (VNDA) - פילוחי מדדים ודוחות פיננסיים

Operating margin reflects the efficiency of profit generation from core business operations before accounting for financial expenses and taxes. Analyzing operating profitability allows for an assessment of the likelihood that returns will deviate from planned values. This metric measures the company's ability to convert revenue into operating income. For Vanda Pharmaceuticals (VNDA), this figure is supported by the patent protection of Hetlioz. Dominance in narrow CNS niches provides the issuer with significant pricing power.